[go: up one dir, main page]

AU1942995A - New use of growth hormone - Google Patents

New use of growth hormone

Info

Publication number
AU1942995A
AU1942995A AU19429/95A AU1942995A AU1942995A AU 1942995 A AU1942995 A AU 1942995A AU 19429/95 A AU19429/95 A AU 19429/95A AU 1942995 A AU1942995 A AU 1942995A AU 1942995 A AU1942995 A AU 1942995A
Authority
AU
Australia
Prior art keywords
growth hormone
new use
new
hormone
growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU19429/95A
Inventor
Francis Edouard De Zegher
Greta Herman Van Den Berghe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Katholieke Universiteit Leuven
Original Assignee
Katholieke Universiteit Leuven
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NL9401045A external-priority patent/NL9401045A/en
Application filed by Katholieke Universiteit Leuven filed Critical Katholieke Universiteit Leuven
Publication of AU1942995A publication Critical patent/AU1942995A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU19429/95A 1994-03-15 1995-03-15 New use of growth hormone Abandoned AU1942995A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP94200661 1994-03-15
EP94200661 1994-03-15
NL9401045 1994-06-24
NL9401045A NL9401045A (en) 1994-03-15 1994-06-24 Novel use of growth hormone
PCT/BE1995/000022 WO1995024919A1 (en) 1994-03-15 1995-03-15 New use of growth hormone

Publications (1)

Publication Number Publication Date
AU1942995A true AU1942995A (en) 1995-10-03

Family

ID=26136095

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19429/95A Abandoned AU1942995A (en) 1994-03-15 1995-03-15 New use of growth hormone

Country Status (2)

Country Link
AU (1) AU1942995A (en)
WO (1) WO1995024919A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998001152A1 (en) 1996-07-10 1998-01-15 Sumitomo Pharmaceuticals Company, Limited Remedies for eating disturbance
EP1806131A3 (en) * 1996-07-22 2007-08-01 Renovo Limited Use of sex steroid function modulators to treat wounds and fibrotic disorders
EP1501539A1 (en) * 2002-05-03 2005-02-02 Metabolic Pharmaceuticals Ltd. Method for control of depression using c terminal growth hormone (gh) fragment
GB0222014D0 (en) * 2002-09-23 2002-10-30 Leuven K U Res & Dev Mannan-binding lectin
CA2546601A1 (en) 2003-11-19 2005-06-09 Metabasis Therapeutics, Inc. Novel phosphorus-containing thyromimetics
US20090232879A1 (en) 2005-05-26 2009-09-17 Metabasis Therapeutics, Inc. Thyromimetics for the Treatment of Fatty Liver Diseases
BR112019010249A2 (en) 2016-11-21 2019-09-10 Viking Therapeutics Inc glycogen storage disease treatment method
US11707472B2 (en) 2017-06-05 2023-07-25 Viking Therapeutics, Inc. Compositions for the treatment of fibrosis
US11787828B2 (en) 2018-03-22 2023-10-17 Viking Therapeutics, Inc. Crystalline forms and methods of producing crystalline forms of a compound
WO2020117962A1 (en) 2018-12-05 2020-06-11 Viking Therapeutics, Inc. Compositions for the treatment of fibrosis and inflammation
AU2021258544A1 (en) * 2020-04-21 2022-10-27 Tseti, Ioulia Pharmaceutical composition comprising L-triiodothyronine (T3) for use in the treatment of tissue hypoxia and sepsis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089475A (en) * 1989-02-07 1992-02-18 Brigham And Women's Hospital Treatment of ventilator dependency with growth hormone
AU7318691A (en) * 1990-02-02 1991-08-21 Novo Nordisk A/S A method of treating a mammal with a biologically active compound
US5492891A (en) * 1991-09-05 1996-02-20 Novo Nordisk A/S Method for treatment of patients with chronic liver disease
US5783560A (en) * 1993-06-25 1998-07-21 Pharmacia & Upjohn Aktiebolag Use of human growth hormone for preoperative administration

Also Published As

Publication number Publication date
WO1995024919A1 (en) 1995-09-21

Similar Documents

Publication Publication Date Title
AU1868595A (en) Human growth hormone
AU2695795A (en) Piperazine compounds promote release of growth hormone
AU3802493A (en) Surgical endoclip
AU5520998A (en) Reduction of hair growth
AU2601895A (en) Modified insulin-like growth factors
AU6772996A (en) 2-acylaminopropanamides as growth hormone secretagogues
AU1023797A (en) Reduction of hair growth
AU2473195A (en) Single use syringes
AU3599597A (en) Reduction of hair growth
AU5178196A (en) Reduction of hair growth
AU3964795A (en) 4-heterocyclic piperidines promote release of growth hormone
AU9319798A (en) Reduction of hair growth
AU5730298A (en) Reduction of hair growth
AU6724496A (en) 2-acylaminopropanamines as growth hormone secretagogues
AU3011497A (en) Novel human growth factors
AU2630295A (en) 2-acylaminopropanol compound and medical composition
AU1830195A (en) Prostatic growth factor
AU3921993A (en) Novel antler-derived bone growth factors
AU1942995A (en) New use of growth hormone
AU4534596A (en) Compounds with growth hormone releasing properties
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU2893595A (en) Use of muramyl peptide compounds
AU3207195A (en) Growth stimulating factors
AU4534696A (en) Compounds with growth hormone releasing properties
AU6723294A (en) Use of simmondsine